XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.2
Organization and Nature of Operations (Tables)
 6 Months Ended
Jun. 30, 2025
Organization and Nature of Operations [Abstract]  
Schedule of Company’s Subsidiaries Which are Included in Condensed Consolidated Financial Statements

Details of the Company’s subsidiaries which are included in these condensed consolidated financial statements as of June 30, 2025 are as follows:

 

Name of Subsidiary   Place and Date of Incorporation   Percentage of Ownership   Principal Activities
Avalon Healthcare System, Inc. (“AHS”)   Delaware May 18, 2015   100% held by ALBT   Holding company for payroll and other expenses
             
Avalon RT 9 Properties LLC (“Avalon RT 9”)   New Jersey February 7, 2017   100% held by ALBT   Owns and operates an income-producing real property and holds and manages the corporate headquarters
             
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”)   PRC April 29, 2016   100% held by AHS   Not considered an operating entity
             
Genexosome Technologies Inc. (“Genexosome”)   Nevada July 31, 2017   60% held by ALBT    No current activities to report; dormant
             
Avactis Biosciences Inc. (“Avactis”)   Nevada July 18, 2018   60% held by ALBT   Dormant; in process of being dissolved
             
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”)   PRC May 8, 2020   100% held by Avactis   Dormant; in process of being dissolved
             
Avalon Laboratory Services, Inc. (“Avalon Lab”)   Delaware October 14, 2022   100% held by ALBT   No current activities to report; dormant
             
  Q&A Distribution LLC (“Q&A Distribution”)   Texas May 1, 2024   100% held by ALBT   Distributes KetoAir device
             
  Nexus MergerSub Limited (“Nexus”)   BVI February 21, 2025   100% held by ALBT   No current activities to report